Baltimore, MD (PRWEB) October 6, 2006
Baltimore-based personal injury law firm Ingerman & Horwitz LLP has recently published information on its website as related to Fosamax, a Merck drug approved for those suffering with Osteoporosis.
The law firm claims it has received inquiries from citizens regarding possible side effects related to their use of Fosamax. The firm does not yet have a suit against Merck, but rather is currently investigating the issue to assess the merits of possible case.
This new interest in hearing from Fosamax users fits in with firm's traditional practice areas of personal injury, product liability and medical malpractice. The partners at Ingerman & Horwitz have over 100 years of combined legal experience.
According to an article on CNN Money (http://money.cnn.com/2006/05/08/news/companies/fosamax/), there were 15 cases filed against Merck in relation to Fosamax as of May 9, 2006. The article did not cite case numbers.
Ingerman & Horwitz LLP has published resources on its website at http://www.ihlaw.com/topics/fosamax/information/ that provide additional fosamax health and legal information including additional side effects and symptoms that individuals have reported. It should be noted that the information published on their site is reported by users and does not necessarily represent a professional medical opinion.
For anyone taking Fosamax, it would be in their best interest to pay careful attention to any unusual reactions until studies can accurate confirm or deny any serious health effects.
More information about Fosamax-related legal rights can be found at http://www.ihlaw.com/fosamax/ or by contacting your doctor or lawyer.
For more information please contact Baltimore, Maryland-based law firm of Ingerman & Horwitz LLP at http://www.ihlaw.com or 1-800-776-4529.